Application of colon bacillus OmpA as animal immunity regulator

A technology of Escherichia coli and animal immunization, which is applied in the direction of medical preparations containing active ingredients, drug combinations, and resistance to vector-borne diseases, etc.

Inactive Publication Date: 2008-07-23
SUN YAT SEN UNIV
View PDF0 Cites 11 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Before the present invention was published, there was no publication or report on the immune regulation function of Escherichia coli OmpA mentioned in this patent application

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of colon bacillus OmpA as animal immunity regulator
  • Application of colon bacillus OmpA as animal immunity regulator
  • Application of colon bacillus OmpA as animal immunity regulator

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0014] Immunomodulatory effect of Escherichia coli OmpA gene deletion strain

[0015] 1. Bacterial culture: Escherichia coli OmpA gene deletion strain was obtained from Nara Institute of Science and Technology, Japan. Pick a single colony and culture it overnight in LB medium, then inoculate it in LB medium at a ratio of 1:100, culture to OD1.0; centrifuge to obtain bacteria. At the same time, the source strain of Escherichia coli OmpA gene deletion strain was used as the control strain.

[0016] 2. Immunization of mice: domesticate the bought mice for 1 week, and feed artificial compound feed twice a day in the morning and evening. The mice with no abnormality after 1 week of domestication were divided into groups. Take the purified bacteria prepared above as immunogen, and immunize mice by intraperitoneal injection, 10 9 / Only. Three injections were given, the second injection was given 14 days after the first injection, and the third injection was given 7 days later. B...

Embodiment 2

[0018] Preparation and purification of Escherichia coli OmpA

[0019] In this example, the full-length Escherichia coli OmpA coding sequence or fragments were constructed into the E. coli protein prokaryotic expression vector to express and purify the target protein.

[0020] The coding sequence of OmpA gene is as follows:

[0021] 1 ttaagcctgc ggctgagtta caacgtcttt gataccttta acttcgatct ctacgcgacg

[0022] 61 atccggagcc aggcagtcga tcagtgcagc acgctgtttc acgttgtcac aggtgttgcc

[0023] 121 agtaaccggg ttggattcgc ccataccacg tgcggagatc ttgtctgccg ggataccttt

[0024] 181 ggagatcagg taatcaacaa cagactgagc acggcgctcg gacagaccct ggttgtaagc

[0025] 241 gtcagaaccg atgcggtcgg tgtaacccag aacaactacg gaaccgtctt tcggatccag

[0026] 301 gttgctcagc tggctgtaca gctgatccag agcagcctga ccttccggtt tcagggttgc

[0027] 361 tttgttgaag ttgaacagaa cgtcagactt cagagtgaag tgcttggtct gtacttccgg

[0028] 421 tgccggagct ggagccggag caactactgg agctgcttcg ccctgaccga aacggtagga

[0029] 481 aacac...

Embodiment 3

[0054] The immune enhancement effect of E. coli OmpA:

[0055] 1. Mice immunization: domesticate the bought mice for 1 week, and feed artificial compound feed twice a day in the morning and evening. The mice with no abnormality after 1 week of domestication were divided into groups. Take the purified OmpA and mix it with an equal volume of complete adjuvant (lanolin: paraffin oil = 1:4v / v, BCG: 30mg / ml), and after repeated suction with a syringe, ultrasonic treatment for 2min, the prepared antigen is injected intraperitoneally Immune mice, 80-100μg / only, the control group does not receive immune treatment. Inject 3 times with an interval of 10 days. The second and third times in the experimental group were mixed with incomplete adjuvant and purified protein before immunization. Blood was collected on the fifth day after the third immunization, and the serum immune titer was detected by Dot-ELISA method.

[0056] 2. Determination of serum titer: Dot-ELISA technology was used...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to the immune-modulating function of outer membrane protein A (OmpA) expressed by Escherichia coli (E. coli). The invention provides that the Escherichia coli OmpA has the efficacy of adjusting the immune function of animals and improving the antiviral ability of animals through a series of experiments such as the immune-modulating effect of Escherichia coli OmpA gene-deleted grains, purification of the immune enhancement effect of the Escherichia coli OmpA and the Escherichia coli OmpA antiserum passive immune enhancement effect.

Description

technical field [0001] The invention relates to the immune regulation function of an outer membrane protein A (outer membrane protein A, OmpA) expressed by Escherichia coli (E. coli). Background technique [0002] An immunomodulator is a function (compound, protein, polysaccharide, drug) that can specifically or non-specifically increase or decrease the immune response, that is to say, it can be a synergist (adjuvant), or an immunostimulator or immune Inhibitors. [0003] In aquatic animal breeding, various chemical drugs and antibiotics are often used to control related diseases, but long-term use of drugs not only leads to more and more drug resistance of pathogenic bacteria, but also makes the hazards of drug residues increasingly apparent, seriously affecting the safety of aquatic products . In these cases, immunomodulators for aquaculture animals came into being. Immunomodulators are also called immunopotentiators or immunostimulators. When used together with antigen...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K39/108A61K38/16A61P37/02
CPCY02A50/30
Inventor 李惠黄传钟林向民王三英彭宣宪
Owner SUN YAT SEN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap